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ABSTRACT 
Cognitive decline in old age is normative, but decline can be exacerbated in individuals 
with Alzheimer’s disease (AD) risk factors. Recent studies suggest that certain dietary regimens 
may slow or exacerbate this decline. However, it is uncertain how changes in whole food 
consumption affects fluid intelligence (FI) performance, an index of reasoning ability, in adults 
with or without AD genetic risk over time. Genetic risk for Alzheimer’s disease (AD) is mostly 
found on Chromosome 19 in the APOE-TOMM40-APOC1 region. Specifically, the 
Apolipoprotein E ε4 (APOE4) haplotype confers the greatest genetic risk for late-onset 
Alzheimer’s disease (AD).  
Food Frequency Questionnaire and Fluid Intelligence Test scores, assessed three times 
across 6 years, were obtained from UK Biobank to cross-sectionally and longitudinally examine 
which whole foods were most related to FI.  Results indicated that both non-carriers (APOE4-) 
and especially carriers (APOE4+) showed increased FI with daily cheese and alcohol 
consumption at baseline. Conversely, decreased FI was seen among APOE4- with daily 
vegetable consumption over time. Among APOE4+, regular salt use showed worse FI scores 
over time. Our findings broadly suggest that reducing FI-related cognitive decline may be related 
to limiting meat, salt, and vegetable consumption, while increasing intake of wheat products, 
cheese, as well as the consumption of alcohol in moderation. Food recommendations, with AD 
genetic and family history factors in consideration, may minimize cognitive decline.  
Translocase of Outer Mitochondrial Membrane-40 (TOMM40) is the only nuclear-
encoded gene that controls mitochondrial protein transport, which is critical for maintaining 
cellular bioenergetics and is progressively disrupted in AD. TOMM40 rs2075650 (‘650) is one of 
the most consistent loci to show associations with several neural and cognitive outcomes relevant 
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to AD. For example, TOMM40 ‘650 genotypes might affect neural network strength, an early 
brain marker that is disrupted along the AD continuum. Therefore, 21 orthogonally derived 
neural networks were examined among 8,222 participants in the UK Biobank cohort. Results 
indicated that TOMM40 ‘650 G allele may be related to functional connectivity in auditory and 
language comprehension areas. This relationship may be modified by sex interactions. 
Differences were observed between G carriers and non-carriers among males, but not females. 
Not surprisingly, APOE4 was associated with several neural networks that share brain topology 
generally affected by AD pathology. 
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CHAPTER 1. GENERAL INTRODUCTION 
The 2018 US Census Bureau predicts that the population size of older adults will exceed 
that of young children. Aging raises vulnerability to cognitive decline and dementia. Typically, 
older adulthood is accompanied by  diminishing quality of life. Genetic and lifestyle factors can 
contribute to brain health and dementia. The common type of dementia is Alzheimer’s disease, a 
neurodegenerative disorder related to multiple components of known and unknown etiology. 
This has been a costly public health challenge to find the cure. Dietary interventions with genetic 
risk factors in consideration could improve brain health and slow or prevent cognitive decline.      
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CHAPTER 2. MORE CHEESE, LESS SALT: CONSUMPTION OF WHOLE FOODS, 
CHANGES IN FLUID INTELLIGENCE, AND THE INFLUENCE OF ALZHEIMER’S 
DISEASE GENETIC FACTORS  
Modified from a manuscript to be submitted to Journal of Alzheimer’s Disease 
Authors: Scott T. Le, B.S.1* , Brandon S. Klinedinst, M.S.1*, Brittany Larsen, M.S., R.D.N., 
L.D.1, Colleen Pappas, Ph.D.1, Qian Wang, Ph.D.1, Yueying Wang, M.S.2, Shan Yu, M.S.2, Li 
Wang, Ph.D2, Karin Allenspach, Ph.D.3, Jonathan P. Mochel, Ph.D.4, David A. Bennett, M.D.5, 
and Auriel A. Willette, Ph.D., M.S.1,4,6 
(1) Department of Food Science and Human Nutrition, Iowa State University, Ames, IA, USA 
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Introduction 
Normal aging is characterized by relatively modest loss in verbal memory and 
crystallized intelligence, which encompasses facts, experiences, and use of prior experience to 
inform actions. By contrast, progressive decline occurs in raw processing speed and higher-order 
cognitive domains, such as executive function (Glisky, 2007). Executive function consists of 
distinctive, multi-component processes such as response inhibition, attention, judgment, and 
regulation of other cognitive domains (Salthouse et al., 2003), which typically peaks in the late 
teens and shows decline in mid- and late life (Lewis and Todd, 2007; Verhaeghen and Cerella, 
2002). The most adversely affected executive function by age is arguably fluid intelligence (FI), 
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which is the capacity for abstract reasoning and problem-solving without background 
information (Cattell, 1971).  
Alzheimer’s disease (AD) is a global public health concern (Brookmeyer et al., 2018), in 
part because executive function deficits often occur in concert with progressive learning and 
memory deficits (Karantzoulis and Galvin, 2011). Additionally, otherwise asymptomatic carriers 
of AD genetic risk factors like apolipoprotein E ε4 allele (APOE4), or a parental family history 
(FH) of AD, tend to show cognitive decline (Bendlin et al., 2010; Bretsky et al., 2003; Small et 
al., 2004; Wisdom et al., 2011). Observing changes in executive function over time in normal 
aging vs. genetically at-risk adults may offer valuable insight into subtle cognitive impairments 
that may serve as early cognitive markers of AD (Clark et al., 2012). Likewise, examining 
modifiable lifestyle factors that impact FI would be useful for future hypothesis testing. 
Recently, lifestyle modification therapies, such as the Mediterranean-Dietary Approaches 
to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) diet, has been 
associated with slower cognitive decline and reduced incidence of AD (Morris et al., 2015b, 
2015a). More cortical thickness in temporal and frontal areas relevant to AD is also seen in non-
demented adults who maintain a higher adherence to a Mediterranean diet (Staubo et al., 2017), 
which is rich in plant-based food sources and healthy fats (monounsaturated and polyunsaturated 
fats) and lower in red meats that are not lean. Thus, improving one’s dietary practices in mid- or 
late-life may be beneficial for preserving cognition (Lehtisalo et al., 2019). Importantly, APOE4 
status or parental FH of AD may influence how dietary patterns are related to cognition over 
time. For example, semi-weekly consumption of fatty fish may be a protective factor against 
dementia but only for non-APOE4 carriers (Huang et al., 2005). Since current therapeutic 
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strategies to modulate AD have not been effective so far (Cummings et al., 2014), targeting 
specific aspects of one’s diet may be a potential preventative strategy to consider.  
Our main objectives in this study were to test: 1) associations between total FI score and 
self-reported whole food intake, in contrast to predefined dietary patterns or nutrients, at baseline 
and 2) associations between total FI score and self-reported whole-food intake gathered over a 
six-year period at 3 visits for the following subgroups (APOE4+ vs APOE4-; FH+ vs FH-).  We 
considered FI over other cognitive domains because a factor analytic study using UK Biobank 
demonstrated that FI had the strongest association with other cognitive measures, especially 
numeric memory scores (Lyall et al., 2016).  
Materials and Methods 
Cohort 
 The United Kingdom (UK) Biobank cohort includes a half million participants, aged 40 
to 80 years, from 22 assessment centers located in the United Kingdom. The study design has 
been described elsewhere (Sudlow et al., 2015). Participants completed informed consent prior to 
baseline examination. Participants (n=1,929) had complete cognitive, demographic, dietary, and 
physical activity data (see Supplementary Figure 2.1).    
Longitudinal Measurement of Fluid Intelligence 
 Participants completed the Fluid Intelligence Test (FIT) as part of a touchscreen 
questionnaire at baseline and two follow-up assessments (2008, 2012, and 2014). The FIT score 
is quantified by how many numeric, logic, and syntactic questions (out of 13 total questions) that 
participants were able to answer correctly within two minutes (Lyall et al., 2016). 
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Assessment of Long-term Dietary Patterns 
Participants answered questions about their food and alcohol consumption as part of a 
touchscreen questionnaire at baseline and two follow-up assessments (2008, 2012, and 2014). 
The Food Frequency Questionnaire inquired about their intake of fresh fruit, dried fruit, raw 
vegetables and salad, cooked vegetables, oily fish, lean fish, processed meat, poultry, beef, lamb, 
pork, cheese, bread, cereal, beer and cider, red wine, white wine and champagne, and liquor. 
Bread, cereal, fruit, and vegetable responses were recorded in integer units (slices per week, 
bowls per week, pieces per day, and tablespoons per day, respectively). Intakes of meat, fish, and 
cheese responses were recorded as dichotomous variables (“less than once a week”, “once a 
week”, “two to four times a week”, “five or six times a week”, “once or more daily”) that were 
contrasted to those who recorded they never consumed the respective food. Alcohol consumption 
responses were recorded by type as an average weekly intake (in pints for beer and cider, glasses 
for red and white wine and champagne, and measures for liquor). Frequency of alcohol intake 
was also recorded as dichotomous variables (“daily or almost daily”, “three or four times a 
week”, “once or twice a week”, “special occasions only”) that were contrasted to those who 
recorded they never consumed alcohol. Bread and cereal intake categories were combined to 
estimate total grain intake. Fresh and dried fruit intake categories were combined to estimate 
total fruit intake. Raw and cooked vegetable intake categories were combined to estimate total 
vegetable intake.  
Considerations of Medical Exclusion Criteria 
Many conditions, particularly in midlife to late-life adults with obesity, are related to 
chronic systemic inflammation, which may influence cognitive function. Consequently, to 
explore if these conditions influenced initial model fitting, we excluded participants with 
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International Classification of Diseases, Tenth Revision (ICD-10) codes reflecting a systemic 
inflammatory condition in their medical record since 2007. Examples included most diseases of 
the digestive system (XI), such as ulcerative colitis (K51) or diverticulitis (K57); chronic lower 
respiratory diseases (J40-J47); and malignant neoplasms of the digestive organs (C15-C26). 
However, because our results did not significantly differ based on these exclusion criteria, data 
from these participants were included in our final models. We also initially excluded participants 
who had any cerebrovascular disease (I60-I69) or disorder of the nervous system (G00-G99). 
However, our pattern of results did not significantly differ based on these excluded participants. 
Consequently, data from these participants were included in the final models as well. 
Genetic Factors - APOE and AD Family History 
All UK Biobank genome-wide association study (GWAS) data have been processed as 
previously described (Sudlow et al., 2015). Briefly, APOE haplotype was determined using allele 
variation on rs429358 and rs7412 (G. Davies et al., 2014). APOE was further stratified as 
whether participant has at least one ε4 allele (ε2/ε4, ε3/ε4, and ε4/ε4) or not at all (ε2/ε2, ε2/ε3, 
and ε3/ε3). AD family history was classified according to the participants’ self-report responses 
of the presence or absence of AD in their family history on the touchscreen questionnaire. 
Specifically, participants were queried about family history via the question, “Has/did your 
father/mother ever suffer from:”, followed by a list of chronic diseases, including ‘Alzheimer’s 
disease/dementia.’  
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Statistical Analyses 
Longitudinal Modeling 
 For FIT, we used difference equations to compute each individual’s linear change over 
time (velocity) to enhance model fit (Shaw et al., 2006). Initial values observed and velocity 
were modeled together as cognitive outcomes in a system of equations in order to test how 
dietary parameters influence the trajectory of cognitive decline throughout the range of age 
observed here. For dietary predictors, we used difference equations to compute each individual’s 
across-time averages and linear change over time. We then integrated these values to derive 
average levels and the sum of changes in order to estimate the total amount consumed for each 
product (Pruessner et al., 2003). This method has demonstrated superior goodness-of-fit, 
increasing testing power, and has elucidating relationships between variables more robust by 
capturing both within- and between-subject variation over time (Duncan and Duncan, 2004; Hu 
and Bentler, 1999; Klinedinst, 2017; Preacher, 2008). 
Outlier Analysis 
 In order to ensure that our models were generalizable to at least 99% of the sample 
population, 1% quantiles were computed, and participants beyond 99% of the sample distribution 
of the mean among any variable were removed from further analysis. This resulted in a final 
sample size of 1,787 and 1,326 for FH and APOE models, respectively.  
Group-stratified Structural Equation Models  
 Structural equation modeling (SEM) was done using lavaan package from R 3.4.1 (R 
Foundation for Statistical Programming, Vienna, Austria) (Rosseel, 2012). Graphs were prepared 
in ggplot2 3.1.1 (Wickham, 2019). Four separate SEMs were built to identify differences 
8 
 
between: 1) Family History Negative; 2) Family History Positive, 3) ApoE4 Negative, and 4) 
ApoE4 Positive participants. To account for confounding demographics and other lifestyle 
variables, models controlled for education, sex, social class as defined by Townsend Deprivation 
Index, body mass index (BMI), and tobacco use. Education was separated into three variables 
and coded as whether they had the following or not: college or higher qualifications; post-
secondary or vocational; and secondary. Townsend Deprivation Index is a standardized score 
that reflects poverty as measured by material deprivation in a population per zip code (Phillimore 
et al., 1994). 
Variable Selection  
An empirical model-building approach was employed to select the most salient variables 
that predicted FI for each subgroup. In this backward elimination approach a full, “all variables 
in” model was built, and the least significant variable was removed one at a time until all 
variables remaining reached p<0.05. 
Parameter Estimation, ANOVA, Uncertainty Analysis 
Standardized parameter estimates (β), which were interpreted as the change in outcome 
variable per standard deviation change in the predictor, were estimated using a maximum 
likelihood approach. ANOVA was reported as the overall portion of variation in FI scores that is 
explained (R2). Uncertainty analysis relied upon standard errors and p-values estimates, where 
results were considered statistically significant at p<0.001 (***), p<0.01 (**), and p<0.05 (*). 
Only participants with all available data were considered for analysis (i.e., no missingness 
imputation was done). 
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Post Hoc Analysis 
 To assess whether any observations were driving the results, the Cook’s Distance was 
calculated for each observation in the base and moderation models. The largest value in the base 
model and moderation model was 0.012 and 0.015, respectively. Any values less than 1.0 are of 
no concern, and we therefore made no further adjustments to the models. 
Results 
Demographics and Data Summaries 
The demographics for APOE and FH subgroups were presented in Table 2.1. There was 
slight male majority across all four subgroups. The majority of each subgroup were highly 
educated. We did not observe major differences between groups in BMI, FI score at baseline nor 
Townsend Deprivation Index.   
Main Effects on Fluid Intelligence Scores 
We examined differences of dietary effect on FI based on APOE haplotype (ε4 carriage 
versus non-carriage) or family history of AD. Aside from food, those who attended college or 
post-college had strong positive significant association with FI at baseline regardless of APOE4 
status, as well as family history (p<0.001).   
Associations with Diet by Genetic Factors Subgroups 
 The standardized beta estimates are presented in Table 2.2. For APOE4 status, both non-
carriers (APOE4-) and especially carriers (APOE4+) showed increased FI with daily cheese 
(APOE4-: β=.073, p=.008; APOE4+: β=.162, p=.001) at baseline, but no relation was observed 
over time (see Figure 2.1). Though among APOE4+ only, there was a positive association 
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between FI and weekly cheese over time (β=.109, p=.025). Daily alcohol consumption was 
related to greater FI at baseline among only APOE4+ (β=.101, p=.023) (see Figure 2.2). Greater 
red wine consumption was related to increased FI at baseline in APOE4- instead, (β=.059, 
p=.039). Conversely, decreased FI was seen in APOE4- with daily vegetable consumption (β=-
.070, p=.023) over time, while for APOE4+ usually salting showed worse FI scores (β=-.121, 
p=.009) over time (see Figure 2.3).  
Associations with Diet by Family History Subgroups 
The standardized beta estimates are presented in Table 2.3. For adults without family 
history, increased FI was related to daily cheese intake (β=.207, p<.001) at baseline, while daily 
poultry (β=-.096, p=.003) or vegetable (β=-.072, p=.005) consumption was associated with more 
rapid decline at baseline. Significant associations of these variables and changes in FI over time 
were not observed. For adults with AD family history, daily whole grain (β=.080, p=.035) at 
baseline and red wine (β=.100, p=.014) consumption predicted higher FI levels over time. FI had 
a negative association with tea intake (β=-.090, p=.015) and processed meat intake (β=-.098, 
p=.006) at baseline. More sporadic intake of poultry and salt were also associated with worse FI 
scores. Figure 2.3 illustrated the association of added salt frequency on change in fluid intellect.   
Discussion 
 The objective of this study was to better understand the relation between whole-foods 
diet composition and changes in FI, among participants stratified by APOE4 carriage status and 
family history status. Our results suggested that whole-foods could affect FI both cross-
sectionally and longitudinally. However, differences are present between subgroups for APOE 
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and FH. Additionally, there are variables that appeared influential at baseline but not over time 
and vice-versa.  
Greater dairy intake may be associated with declining memory in older adults who have 
heart failure, possibly due to the high fat contained in dairy products. Dairy products may then, 
in turn, contribute to an alteration in blood pressure, consequently affecting memory (Garcia et 
al., 2015). This association may suggest cheese intake to be unhealthy. On the other hand, dairy 
consumption may prevent cognitive decline in men without cardiovascular disease sequelae due 
to calcium and vitamin B12, independent of genetic and family environmental factors (Ogata et 
al., 2016). Differences in the fat content of dairy products may be related to improvements in 
spatial working memory (Crichton et al., 2012). However, it is largely unknown how whole fat 
vs. low fat or nonfat dairy options would affect such outcomes (Rubin, 2018). Thus, dairy 
consumption may be beneficial in other ways. For example, lactopeptides may improve 
cognition in older adults (Ano et al., 2018), and probiotics may attenuate depression 
(Steenbergen et al., 2015).  
We also found that, when distinguishing different sources of alcohol, greater red wine 
consumption over time was related to better FIT scores. Among cognitively normal aged adults, 
low, but not moderate or heavy consumption of wine, has been associated with improved 
cognitive performance, white matter integrity, and cerebral blood flow (Haller et al., 2018). 
Another observational study found that, in contrast to abstainers, light to moderate beer 
consumption was associated with a higher risk of dementia, while light to moderate wine 
consumption was associated with a significantly lower risk (Deng et al., 2006). This is consistent 
with the findings of one large observational, cross-sectional cohort study consisting of 1,624 
older participants (mean age±SD = 73.2±9.3 years), which found a link between the amount and 
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frequency of alcohol intake and cognitive function (Reas et al., 2016). Interestingly, the study 
found that moderate, regular alcohol consumption related to improved cognitive function in 
comparison to abstainers of alcohol, supporting that utilizing alcohol in moderation is unlikely to 
result in adverse effects in the geriatric population. Furthermore, when assessed by APOE status, 
the study found no significant difference between APOE genotype and the alcohol-cognition 
relationship, which contradicts our findings. The mechanisms underlying how moderate alcohol 
consumption may be neuroprotective have yet to be fully elucidated. However, research has 
shown that alcohol used in moderation may have beneficial cardiovascular-associated effects 
(including higher high-density lipoprotein, decreased blood pressure, and increased anti-
inflammatory properties), which, in turn, may result in better cognitive function (Hines and 
Rimm, 2001; Ronksley et al., 2011). Alternatively, the alcohol-cognitive link may also be 
explained by prior evidence suggesting that alcohol could be directly mediated by certain 
neuroprotective factors, including the reduction of neuroinflammation, oxidative stress, and 
apoptosis (Bate and Williams, 2011; Liao et al., 2003). However, more research is needed to 
elucidate the biological underpinnings of alcohol’s effects on cognition. 
It is important to note that the Reas et al. study failed to differentiate between the types of 
alcohol consumed (wine, beer, and liquor) in the results. This is noteworthy, as prior literature 
has shown that this benefit is more pronounced with wine consumption than with beer or liquor 
consumption (Arntzen et al., 2010; Truelsen et al., 2002). Although alcohol induces oxidative 
stress, red wine may counteract this because of its polyphenolic content (Berman et al., 2017; 
Hernández et al., 2016). Furthermore, we did observe a significant association between red wine 
and higher FI in our data, but only in those with a APOE4- genotype or a family history of 
13 
 
Alzheimer’s disease. Those who were APOE4+ or had no family history of Alzheimer’s disease, 
on the other hand, showed no such association.  
Across participants without the aforementioned AD risk factors, vegetable consumption 
was negatively correlated with FI over time for APOE4- adults and at baseline for FH- adults. 
Cruciferous vegetables (i.e. broccoli and kale) are beneficial because they are rich in 
micronutrients, flavonoids, and antioxidants (Morris et al., 2018). Contrarily, starch-rich 
vegetables have a higher glycemic load and may elevate the risk for hypertension by inducing 
oxidative stress (Huang et al., 2019; Lea et al., 2016), which in turn may drive cognitive 
impairment and AD progression (Sultana and Butterfield, 2010). Thus, vegetable associations 
may be driven by starch-rich or fried vegetables. However, our study could not discern the type.   
Our data supports that excess dietary salt intake appears to harm cognition, especially for 
individuals with the presence of FH or APOE4. Prior research has shown a link between salt-rich 
diets and cognitive decline. For example, an experimental study using mice who were fed either 
eight-fold or sixteen-fold over the recommended amount of dietary salt in a mouse’s daily diet 
that after approximately eight to 12 weeks of following this diet, the mice began manifesting 
cognitive decline and memory difficulties (Faraco et al., 2018). For instance, they have 
increasing difficulty with differentiating new vs. familiar objects, completing mazes, and 
building nests. Although the mechanisms behind how salt negatively affects brain health are not 
fully understood, the authors purported that physiological disturbances such as hinderance of 
resting cerebral blood flow and endothelial function caused by excess salt intake is likely to be 
applicable to humans as well.  
However, the studies examining associations between dietary salt consumption and 
cognition appear to be inconclusive in humans (Kendig and Morris, 2019). Stratification of 
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dataset into AD risk factors, such as done in our study, potentially elucidated this relationship. 
For instance, we found that FI scores were consistent regardless of the amount of salt consumed 
for participants lacking either FH AD or APOE4, but always salting appeared to be detrimental 
for participants who were found to have either aforementioned AD risk factor. Individuals with 
FH of AD, specifically maternal, who were cognitively unimpaired were shown to have reduced 
brain glucose metabolism (Mosconi et al., 2007). Thus, this predisposition may not handle high 
salt intake and therefore impair cognition.  However, more research is needed to elucidate the 
mechanisms that may be involved in the correlation between dietary salt intake and cognition in 
humans.  
FH is a unique risk factor that may reflect developmental and or environmental 
influences, such as dietary habits, which could modulate neurodegeneration (Donix et al., 2012). 
Although Donix and colleagues found that subjects with FH had lower baseline scores in general 
cognitive performance, no significant decline were detected longitudinally. However, the 
difference in findings may be due to the length of time with their study having one follow-up 
assessments over a period of approximately two years versus ours having two follow-up 
assessments over a period of six years. Gut microbiota and the brain conjunctively form an axis 
and have interlinked health outcomes via vagal afferents (Ambrosini et al., 2019; Mayer et al., 
2015). Greater diversity in the microbiome has been associated with reduced risk of AD (Vogt et 
al., 2017) and better ability to digest nutrients (Petersen et al., 2019). Not only does the intestinal 
microbiome affect absorption potential, but diet can also impact the diversity and metabolic 
capacity of gut flora and alter body composition (Turnbaugh et al., 2009). A FH of AD may 
modify how the brain utilizes β-carotene and may be related to other beneficial effects, such as 
higher regional glucose metabolism in AD-sensitive brain areas (Mosconi et al., 2014). In other 
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words, FH of AD may moderate how diet and cognition are related because it reflects inter-
individual differences in the ability to harbor a healthy diversity of gut bacteria, which alters how 
food is metabolized and which nutrients are extracted. 
There are several limitations that should be considered in our study. Although we utilized 
longitudinal data for predictors and outcomes, this is an observational study and the direction of 
causality cannot be inferred. Additionally, associations may also reflect effects from an 
unmodeled third variable. Our study had nevertheless several strengths worth noting. First, 
unlike cross-sectional self-reporting of food intake studies, which may underestimate or 
overestimate consumption, we accounted for individual variation and reduced error variance by 
considering dietary recall at three time-points over six years. In addition, we also used agnostic 
statistical analyses to parse which food groups were related to FIT scores, rather than derive 
scores for adherence to a specific diet type. By identifying effects from individual food 
categories, Mediterranean and MIND diet recommendations could be further improved.  
In summary, our findings suggest that weekly cheese intake over six years is associated 
with better fluid intelligence performance for APOE4+ adults. Though daily cheese intake 
appeared beneficial regardless of APOE4 carrier status at baseline. The association between FI 
and certain food may differ between people stratified by AD family history and between people 
stratified by APOE4 carrier status. Thus, meal plans may need to be modified to meet individual 
needs in order to potentially minimize cognitive decline. Future work may examine how other 
cognitive domains (i.e. spatial memory), brain volume and white matter microstructure are 
affected by whole food dietary components. 
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Figures and Tables 
 
Figure 2.1. Association of Cheese Frequency on Fluid Intellect by FH and APOE4 Subgroup. 
 
Velocity is change over time. The red dotted lines represent the performing group with highest  
fluid intellect level at baseline. 
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Figure 2.2. Association of Alcohol Frequency and Red Wine Intake on Fluid Intellect by FH and 
APOE4 Subgroup. 
 
Velocity is change over time. The red dotted lines represent the performing group with highest 
fluid intellect level at baseline.  
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Figure 2.3. Association of Added Salt Frequency on Fluid Intellect by FH and APOE4 
Subgroup.  
 
Velocity is change over time. The red dotted lines represent the performing group with highest 
fluid intellect level at baseline.  
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Table 2.1. Data summary stratified by APOE subgroups and Family History Factors 
Data, measurement unit APOE4- APOE4+ FH- FH+ 
Sample Size (n) 967 359 1305 482 
Age (y) 63 ± 7.4 62 ± 7.2 63 ± 7.6 64 ± 6.5 
Sex (Female:Male) 470:497 164:195  619:686 226:256 
College Plus (n, %) 651 (67.3%) 253 (70.5%) 861 (66.0%) 345 (71.6%) 
BMI 26 ± 4.2 26 ± 3.8 26 ± 4.2 26 ± 4.0 
Fluid Intellect Baseline 6.9 ± 1.9 6.8 ± 2.1 6.8 ± 2.0 7.0 ± 1.9 
Townsend Deprivation Index -2.4 ± 2.4 -2.4 ± 2.3 -2.3 ± 2.4 -2.3 ± 2.5 
The values are mean ± SD unless stated otherwise. Years is abbreviated y. Body mass index is 
abbreviated BMI. 
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Table 2.2. Standardized Estimates of predictors on fluid intelligence by APOE4 status   
Predictor Models 
APOE4- (n=967)  APOE4+ (n=359) 
Intercept Velocity  Intercept Velocity 
Cheese Daily 0.073**   0.162**  
Red Wine 0.059*     
Vegetables  -0.070*    
Moderate Activity -0.082**   -0.149***  
Poultry Rarely    -0.134** 0.134** 
Lamb Rarely    0.097*  
Processed Meat Rarely    -0.276** 0.287*** 
Processed Meat Weekly    -0.370*** 0.286*** 
Processed Meat Daily    -0.179** 0.126* 
Daily Alcohol    0.101*  
Usually Salts     -0.121** 
Cheese Weekly     0.109* 
Lean Fish Rarely     -0.326** 
Lean Fish Weekly     -0.245** 
*p<.05, **p<.01, ***p<.001.  
 
Table 2.3. Standardized Estimates of predictors on fluid intelligence by Family History status    
Predictor Models 
FH- (n=1305)  FH+ (n=482) 
Intercept Velocity  Intercept Velocity 
Cheese Weekly 0.124**     
Lamb Rarely 0.066**     
White Wine 0.064** -0.054#    
Processed Meat Rarely 0.051*   -0.098**  
Weekly Alcohol -0.051*     
Vegetables  -0.072**    
Poultry Daily -0.096**     
Moderate Activity -0.097***     
Poultry Rarely -0.103**   -0.107*  
Poultry Weekly -0.152***   -0.127**  
Grain Substitute     0.100* 
Red Wine     0.100* 
Whole Grains    0.080*  
Usually Salts     -0.079* 
Tea    -0.090*  
Sometimes Salts     -0.114** 
Values are standardized betas. *p<.05, **p<.01, ***p<.001.  
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Supplementary Figure 2.1. Flowchart Diagram of participant selection and exclusion 
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Supplementary Figure 2.2. Timeline of Data Collection 
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Introduction 
The Apolipoprotein E ε4 (APOE ε4) haplotype is the strongest genetic risk factor for late-
onset Alzheimer’s disease (AD), a neurodegenerative disorder characterized by progressive 
cognitive impairment and reduced brain activity both at rest and during task performance 
(Agosta et al., 2012; Corder et al., 1993; Farrer et al., 1997; McKenna et al., 2016). In the 
absence of a task, resting state functional magnetic resonance imaging (rsfMRI) is used to 
examine spontaneous changes over time in the amount of deoxygenated vs. oxygenated blood 
used to meet metabolic demand, a proxy for neural activity at baseline with no task (Ma et al., 
2016). These spontaneous fluctuations are highly correlated within and across certain brain 
regions, resulting in consistent neural networks (Damoiseaux et al., 2006). Neural network 
strength (i.e., functional connectivity or coupling) can discern AD patients from healthy controls, 
as well as individuals with mild cognitive impairment (MCI) who are stable from those who later 
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convert to AD (Binnewijzend et al., 2012; Sorg et al., 2007). Further, these links to less neural 
network strength in older unimpaired adults with APOE4 can manifest without amyloid 
deposition (Sheline et al., 2010), suggesting such changes occur years before AD neuropathology 
begins in earnest and that network strength can act as an early AD neural biomarker.  
The common approach is to focus on one specific network, the Default Mode Network 
(DMN). DMN is an important network to consider because of its vulnerability to AD (Buckner et 
al., 2009). Specifically, this network robustly shows progressively less activity in adults who are 
at-risk, MCI, and AD. DMN consists of bilateral parietal cortex, precuneus and posterior 
cingulate cortex, anterior cingulate cortex, medial prefrontal cortex, hippocampus, and thalamus 
(Binnewijzend et al., 2012), all of which show less glucose metabolism across the AD 
continuum. Hence, the current study examined neural network strength in the DMN, but also 
explore a comprehensive set of other neural networks in a robust sample. Such networks underlie 
neural activity that regulates executive function, emotion regulation, memory recognition, 
association, and other behaviors or internal processes relevant to AD. 
Likewise in genomics, the APOE ε4 allele receives the overwhelming vast majority of 
attention, despite the other two APOE haplogroups. Specifically, it is unclear how the protective 
APOE ε2 allele (Corder et al., 1994) and “neutral risk” ε3 allele differ with regard to activity in 
these non-DMN networks, particularly in the context of other AD risk factors such as age and 
sex. Most especially, it is worthwhile to consider that adjacent genes on Chromosome 19 may 
also be relevant to detecting early hypoactivation in these networks. While several loci on these 
genes are in moderate linkage disequilibrium with APOE, at-risk genotypes may nonetheless 
have effects on neural network function. This would be critically important for early detection of 
participants who will eventually go on to develop AD.  
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In particular, Translocase of Outer Mitochondrial Membrane 40kD (TOMM40) is the 
only nuclear-encoded gene that facilitates mitochondrial protein trafficking and translation, a 
process critical for cellular bioenergetics (Humphries et al., 2005). Many studies have shown that 
a G vs. A single nucleotide polymorphism (SNP) on rs2075650 (‘650) increases the risk for 
normal cognitive decline but also AD (Bagnoli et al., 2013; Harold et al., 2009; Omoumi et al., 
2014; Valant et al., 2012). It is still open to debate whether the aforementioned TOMM40 
associations merely reflect LD with APOE (Davies et al., 2014; Yu et al., 2007). These studies 
only covaried the number of ε4 alleles, however, without a more careful consideration of the 3 
haplogroups that make up the APOE factor. It may be that APOE ε4 shows independent 
relationships itself, in conjunction with TOMM40 ‘650, or possibly both scenarios depending on 
the phenotype. It may be easier to disentangle such effects using neural networks sensitive to AD 
vs. normal aging, rather than AD risk or cognition which have much more error variance.  
Accordingly, using genetic and rsfMRI data from the UK Biobank cohort (Sudlow et al., 
2015), our objectives were to test the following effects on neural network strength at rest: 1) the 
main effects of the APOE haplotypes and interactions with sex and age; and 2) the main effects 
of TOMM40 ‘650 polymorphism and interactions with sex and age, among all participants. This 
study will clarify how APOE and TOMM40 risk groups influence early neural markers of AD, 
which in turn could improve precision medicine for disease treatment.  
Materials and Methods 
Cohort and Participants 
The UK Biobank cohort includes a half million participants, aged 40 to 80 years, from 22 
assessment centers located in the United Kingdom (Sudlow et al., 2015). The current study 
examined a sub-cohort of 8,222 participants with genomics, MRI, and demographics data. 
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Participants completed informed consent prior to baseline examination. Participants with central 
nervous system disorders, cerebrovascular diseases, and any of the dementias were excluded 
from the sample (see Supplementary Figure 3.1). 
Genotyping 
For TOMM40, genotype data for the SNP ‘650 were extracted for analyses using PLINK 
version 1.90 (https://www.cog-genomics.org/plink/1.9/). TOMM40 ‘650 status was coded as 
those who were non-G carriers (AA homozygotes) versus G-carriers (GA and GG). G has been 
credited as being an AD risk allele (Elias-Sonnenschein et al., 2013). The Hardy-Weinberg 
equilibrium (HWE) for TOMM40 ‘650 was p = 0.6976, indicating that frequency counts for these 
genotypes were in line with the general population. For APOE haplotype, a similar process was 
used for SNPs rs429358 and rs7412. Participants were categorized as having ε2, ε3, or ε4 
isoforms. Participants classified as APOE ε2/ε4 were excluded from analyses.  
Resting State fMRI – Acquisition and Processing 
As described in previous publications (Miller et al., 2016), participants were scanned on one 
of three Siemens Skyra 3T units with a 32-channel RF receiver head coil (Siemens Medical 
Solutions, Erlangen, Germany). Participants were briefly instructed to simply focus on a 
crosshair and not think about anything specifically, and therefore had eyes open. Scan duration 
was 6 minutes and 10 seconds, to acquire 490 images with the following acquisition parameters: 
TR = 735ms; TE = 39ms; 2.4 x 2.4 x 2.4mm voxel resolution; 88 x 88 x 64 matrix, multiband 
factor = 8, in-plane acceleration factor = 1, flip angle 52°. Preprocessing and quality control 
measures are described in UK Biobank white papers 
(https://biobank.ctsu.ox.ac.uk/crystal/crystal/docs/brain_mri.pdf). Briefly, using FSL tools, the 
4D dataset was motion-corrected, grand-mean intensity normalized, high-pass temporal filtered 
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(with sigma = 50.0s), EPI and GDC unwarped and denoised (using ICA+FIX processing). Group 
Principal Component Analysis and Independent Component Analysis through FMRIB’s 
MELODIC were then used to derive 21 spatially orthogonal, non-noise, distinctive Independent 
Components (ICs) that represent resting neural networks. Each participant has a Z-score for a 
given IC, representing the degree of activation relative to the group mean. An expert (AAW) 
then viewed the activation maps and described the neural networks (see Supplementary Table 
3.1).  
Covariates 
For main effect analyses of APOE or TOMM40 ‘650 genotype, covariates included sex, age 
at recruitment, social class, education level, and family history of AD. Social class was 
categorically derived from gross annual household income between 2008 and 2014 as “lower 
class” (<£18,000), “middle class” (£18,000-£51,999), and “upper class” (£52 000 to > £100,000). 
Education level was categorized as: college or higher qualifications (3); post-secondary or 
vocational (2); secondary (1); and, none of the above (0). 
Statistical analysis 
Linear multiple regression equations were modeled using R, version 3.6.1 (R Foundation for 
Statistical Programming, Vienna, Austria). Initial analyses tested the main effect of APOE 
haplotype type (ε2, ε3, ε4) on all 21 neural networks, followed by interactions with age in years 
and sex. The ε3 allele group was set as the reference group. ANCOVA was used in follow-up 
tests to examine differences among APOE groups. Next, we examined the main effect of 
TOMM40 ‘650 G carriage and interactions with age in years and sex. APOE was added to the 
TOMM40 models as a covariate and recoded as a dichotomous variable based on whether the 
participant carried ε4 or not (APOE4+ vs APOE4-). These analyses were conducted across all 
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participants. ANCOVA was used in follow-up tests to examine differences among ‘650 G 
carriage. To address power, sensitivity analyses was conducted for each dataset using GPower 
3.1 (Faul et al., 2009). Significant effects were corrected for multiple comparison using the 
Scheffe method. Family-wise Alpha was set at p=0.05. Estimated marginal means were 
calculated using emmeans (Lenth et al., 2020). The figures were produced using ggplot2 
(Wickham, 2019). 
Results 
Descriptive Statistics 
Our sample included 8,222 participants. Demographic and clinical data are presented in 
Table 3.1. The average age of participants was 55 years (SD = 7.47) and approximately 52% 
were female. Most participants were highly educated. Slightly more than half participants 
reported to be in middle class.  
APOE Main Effects and Interactions  
In contrast with ε3 carriers, ε4 carriers had less functional connectivity in executive 
function, memory retrieval, memory storage, motor planning, and language processing networks 
(see Figure 3.1 and Table 3.2). Figure 3.2 illustrates functional connectivity in posterior default 
mode network across APOE groups. Conversely, ε2 carriers had more functional connectivity in 
memory storage and retrieval (see Table 3.2). No age or sex interactions were observed with 
APOE 𝜀4 carriers for any resting state network. Exploratory three-way interactions also yielded 
non-significant results for any network.  
TOMM40 ‘650 Main Effects and Interactions 
 We found an effect of the G-allele in neural networks involved with auditory and language 
comprehension (see Table 3.3). Figure 3.3 illustrated the main effect of G carriage and APOE 
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𝜀4 carriage separately on auditory/language comprehension areas and posterior default mode 
network. The estimated difference between carrier vs. non-carrier men was significant 
(Mdiff=.072, SE=0.0232, p=0.02) in the language comprehension neural network. However, this 
did not apply among women (Mdiff=0.007, SE=0.0223, p>0.10). Additionally, there were no 
significant interactions between TOMM40 ‘650 and age in years for any resting state network. 
Three-way interactions were also examined but yielded no statistically significant effect for any 
resting state network.  
Discussion 
Our objectives for the study was to examine the main effect of APOE and TOMM40 on 
neural network strength. APOE4 was related to less functional connectivity in several resting 
state networks: motor planning, left auditory processing, memory consolidation, primary visual, 
central executive function, cerebellum, posterior default mode network, and top-down cognitive 
processing. Cortical auditory processing has been deemed a relevant biomarker for preclinical 
AD, but not with APOE4 (Tuwaig et al., 2017). Nonetheless, this risk allele has been associated 
with motor decline and worse episodic memory (Buchman et al., 2009; Lim et al., 2017).     
To our knowledge, this was the first study to examine the association between TOMM40 
‘650 and resting state neural networks. TOMM40 ‘650 G carriage appears to specifically affect 
neural networks involved in auditory and language comprehension. Language comprehension is 
tied with Wernicke’s area and has been shown to have predominant long-range connectivity 
(Tomasi and Volkow, 2012). Overall, this may support any effect TOMM40 does have on AD 
vulnerable areas is due to LD with APOE4. 
The effect of TOMM40 ‘650 G carrier status that was observed may be due to sex differences 
seen between G carriers and non-carriers in men but not women. We expected weakened 
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functional connectivity for G carriers, but the effect appeared to be greater for males. Another 
UK Biobank Study observed sex differences in resting state connectivity such as men having 
stronger connectivity between unimodal sensory and motor cortices (Ritchie et al., 2018). While 
we did observe significant sex effects across all neural networks, sex alone is not enough to 
distinguish individual patterns (Weis et al., 2020). Unsurprisingly, age was significantly 
associated with less functional connectivity which has been supported elsewhere (Varangis et al., 
2019). However, the lack of three-way interactions observed could support that multiple 
mechanisms affect functional connectivity separately.  
Despite our study’s strength of a large cohort, there are notable limitations to address.  Since 
our sample comprises of British Europeans, our results may not generalize to the larger 
population. Although TOMM40 ‘650 polymorphisms contributing similarly to AD was observed 
in Caucasian and Asian populations (Huang et al., 2016), this study does not encompass other 
race or ethnicities. The correlations between neural networks may either underestimate or 
overestimate the effect of ‘650 G carriage on one neural network. The current study was cross-
sectional so we could not capture potential changes in functional connectivity. In addition, 
causality cannot be implied because the study was observational.  
The current study may reflect that more neural networks are vulnerable to APOE4 than 
TOMM40 polymorphisms while the latter may have an effect in areas related to language 
comprehension in males. Though, this association may be beneficial or compensatory. A 
thorough examination of the structure among the ‘650 polymorphisms may be able to delineate 
the sensitivity of the Wernicke’s area. Another research suggestion is to genotype older male 
adults without hearing impairment for TOMM40 ‘650 and compare how G carriers understand 
language in contrast to non-G carriers. Future work should examine the associations observed in 
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our study among other ethnic groups to assess generalizability. Assessment of functional 
connectivity at multiple time points may uncover changes with brain atrophy and cognitive 
decline. Novel AD genetic risk factors without LD to APOE should also be examined with 
resting state functional connectivity as an outcome, as aforementioned studies besides the current 
study have demonstrated its utility (Binnewijzend et al., 2012; Sorg et al., 2007).  
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Figures and Tables 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. APOE Allele Carriage and Neural Network Strength In Several Components.  
Refer to Supplementary Table 2.1. Independent Component is abbreviated as IC. Only 
components where significant ε4 were shown. The ε3 haplotype is the reference group.   
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Figure 3.2. APOE Allele Carriage and Neural Network Strength in Posterior Default Mode 
Network 
The ε3 haplotype is the reference group. Independent Component is abbreviated as IC.  
 
Figure 3.3. TOMM40 ‘650 or APOE non-risk vs. risk genotypes and neural network strength in 
Auditory/Language Comprehension Areas and Posterior Default Mode Network 
Independent Component is abbreviated as IC.
* 
* 
* 
* 
** 
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Table 3.1. Participant composition and data characteristics 
Age at recruitment, years 55.12 ± 7.47 
Sex, no (%)  
 Female 4269 (51.9) 
 Male 3953 (48.1) 
Education, no (%)  
College or higher qualifications 5338 (64.9) 
Post-secondary or vocational 1526 (18.6) 
Secondary  943 (11.5) 
None of the above 415 (5.1) 
Social Class, no (%)  
Lower 3644 (44.3) 
Middle 4264 (51.9) 
Upper 314 (3.8)  
Positive Family History of AD, no. (%) 2043 (24.8) 
TOMM40 G carrier, no. (%) 2356 (25.4) 
APOE ε4 carrier, no. (%) 2135 (26.0) 
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Table 3.2. Main Effects and Interactions of APOE Haplotype Groups on Neural Network 
Strength 
  
 
Neural 
Network 
Model I  Model II 
APOE ε2 Group  APOE ε4 Group  APOE ε4 Group * Sex  
β   SE     β       SE  β SE 
1 0.012 0.0189  -0.026 0.0147*  -0.025 0.0293 
2 -0.007 0.0219  -0.015 0.0171  -0.009 0.0341 
3 0.004 0.0169  -0.030 0.0132*  -0.027 0.0263 
4 -0.010 0.0207  -0.020 0.0161  -0.004 0.0322 
5 0.007 0.0165  -0.024 0.0129*  -0.031 0.0256 
6 0.014 0.0152  -0.032 0.0118**  -0.017 0.0236 
7 0.005 0.0149  -0.036 0.0117**  -0.025 0.0232 
8 -0.005 0.0318  -0.029 0.0248**  -0.006 0.0495 
9 -0.003 0.0198  -0.032 0.0154**  -0.013 0.0308 
10 0.005 0.0197  -0.015 0.0153  -0.019 0.0306 
11 0.012 0.0144  -0.013 0.0112  -0.019 0.0224 
12 0.016 0.0158  -0.022 0.0123  -0.023 0.0246 
13 -0.004 0.0124  -0.024 0.0097*  -0.020 0.0193 
14 0.022 0.0100*  -0.004 0.0078  -0.012 0.0156 
15 0.019 0.0101  -0.028 0.0079*  -0.018 0.0157 
16 0.020 0.0144  -0.011 0.0112  -0.025 0.0224 
17 0.015 0.0170  -0.024 0.0133*  -0.015 0.0265 
18 0.009 0.0094  -0.016 0.0073  -0.016 0.0146 
19 -0.006 0.0253  -0.027 0.0197*  0.001 0.0393 
20 0.028 0.0142*  -0.038 0.0111***  -0.009 0.0221 
21 0.010 0.0129  -0.040 0.0101***  -0.033 0.0201 
 
See Supplementary Table 2.1 for descriptions of all 21 independent neural networks. For model 
1, APOE ε3 is the reference group for comparisons with ε2 and ε4. Beta weights are significant 
predictors in the model denoted as: *p<.05, **p<.01, ***p<.001. Estimates that survive 
correction are indicated by bold text.  
Model I:  APOE Groups + Age + Sex + Education + Social Class + Family History AD 
Model II:  APOE Groups + Sex + APOE*Sex + Age + Education + Social Class + Family 
History AD 
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Table 3.3. Main Effects and Interactions of TOMM40 ‘650 G Carriage on Neural Network 
Strength 
 
 
   Neural 
Networks 
Model I  Model II  
‘650 G Carriage   APOE ε4 Carriage        G Carriage * Sex   
β SE  β SE  β SE  
1 0.005 0.0208  -0.033 0.0207*  -0.015 0.0287  
2 -0.011 0.0242  -0.005 0.0240  -0.041 0.0334*  
3 0.028 0.0187  -0.051 0.0186**  -0.020 0.0258  
4 -0.016 0.0228  -0.006 0.0227  -0.016 0.0315  
5 0.021 0.0182  -0.041 0.0181**  -0.033 0.0251  
6 0.000 0.0167  -0.035 0.0166*  -0.002 0.0231  
7 0.015 0.0165  -0.048 0.0164**  -0.021 0.0227  
8 -0.008 0.0350  -0.023 0.0349  -0.020 0.0484  
9 -0.012 0.0218  -0.023 0.0217  -0.044 0.0301*  
10 -0.018 0.0217  -0.003 0.0216  -0.024 0.0299  
11 -0.007 0.0158  -0.011 0.0157  -0.036 0.0219*  
12 -0.021 0.0174  -0.010 0.0173  -0.035 0.0240*  
13 0.010 0.0136  -0.031 0.0136  -0.017 0.0189  
14 0.002 0.0110  -0.011 0.0110  -0.026 0.0153  
15 -0.011 0.0112  -0.025 0.0111  -0.026 0.0154  
16 -0.014 0.0158  -0.005 0.0158  -0.012 0.0219  
17 0.031 0.0187*  -0.050 0.0186**  -0.042 0.0259*  
18 -0.019 0.0103  -0.004 0.0103  -0.039 0.0142*  
19 -0.015 0.0278  -0.015 0.0277  -0.023 0.0385  
20 -0.010 0.0156  -0.038 0.0155*  -0.023 0.0216  
21 0.003 0.0142  -0.044 0.0142**  -0.027 0.0197  
See Supplementary Table 2.1 for descriptions of all 21 independent neural networks. Beta 
weights are significant predictors in the model denoted as: *p<.05, **p<.01, ***p<.001. 
Estimates that survive correction are indicated by bold text.  
Model I: ‘650 G Carrier Status + Age + Sex + Education + Social Class + Family History AD + 
APOE e4 status.  
Model II: ‘650 G Carrier Status + Sex + ‘650 G Carrier Status*Sex + Age Group + Education + 
Social Class + Family History AD + APOE ε4 status 
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Supplementary Figure 3.1. Flowchart Diagram of participant selection and exclusion 
 
Participants with neuroimaging and 
genotyping data (n=12,708) 
Excluded participants diagnosed with 
Central Nervous System disorders, 
Cerebrovascular diseases, and any of 
the dementias (n=565) 
Excluded participants with incomplete 
data (n=3,921) 
Participants with neuroimaging and 
genotyping data (n=12,143) 
Participants with complete data 
included in the final analysis (n=8,222) 
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Supplementary Table 3.1. Interpretation of 21 Independent Components that Constitute Neural 
Networks in UK Biobank 
Independent Component Neural Network Description 
1 Anterior and Posterior Default Mode Network 
2 ‘Where’ and ‘What’ Pathways 
3 Motor Planning Network 
4 Extrastriate Visual Network 
5 Left Executive Function Network 
6 Left Auditory Processing and Speech Production Network 
7 Memory Consolidation Network 
8 Primary Visual Network 
9 Central Executive Function Network 
10 Affect Processing Network 
11 Motor Execution Network 
12 Sensorimotor Network 
13 Right Executive Function Network 
14 Fronto-Cingular Network 
15 Cerebellum Network 
16 Frontopolar Network 
17 Auditory/Language Comprehension 
18 Substantia Nigra Cortico-Striatal Loop 
19 Primary Visual Network 
20 Posterior Default Mode Network 
21 Prefrontal and ‘What’ Pathway Network 
 
Papaya viewer was used to examine the 21 non-noise, orthogonalized neural network maps from 
the 25 Independent Component (IC) solution set originally estimated in 4,181 UK Biobank 
participants (see 
https://www.fmrib.ox.ac.uk/ukbiobank/group_means/rfMRI_ICA_d25_good_nodes.html for link 
to the viewer and maps). An imaging and neuroanatomy expert (AAW) cross-referenced these 
maps with established networks in the literature, as UK Biobank neural network have to our 
knowledge not been extensively described.  
IC1 was “classic” Default Mode Network, with activation in medial prefrontal cortex and the posterior 
cingulate/precuneus region. IC2 showed lateral extrastriate activation in temporo-occipital junctions, 
moving down to inferior temporal gyrus and up to superior temporal gyrus, areas which are consistent 
with the ‘where’ and ‘what’ pathways respectively grading for spatial and object elements of visual 
stimuli. IC3 was predominantly composed of bilateral primary motor, pre-motor, and Supplementary 
Motor Area (SMA) cortices, cerebellum, medial cingulate cortex, and posterior insula, which may 
collectively grade for input and output relevant to motor function. IC4 was composed of extrastriate 
regions with some impingement on primary visual areas, suggesting a network focused on multi-modal 
visual processing. IC5 was “classic” executive network restricted to the left hemisphere, composed of 
inferior frontal and parietal gyri. IC6 had activation in bilateral inferior frontal gyri, pre-SMA, and 
cerebellum, suggesting a network focused on speech production and interpretation. IC7 was a memory 
consolidation network composed of activation in precuneus, posterior cingulate, and lateral parietal 
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cortices that streamed down to medial temporal lobe including parahippocampal gyrus and entorhinal 
cortex, with little activity in hippocampus proper. IC8 showed activation exclusively in posteromedial 
occipital gyrus, suggesting primary visual processing in V1 rather than extrastriate areas seen in IC4. IC9 
was “classic” central executive network and composed of bilateral inferior frontal and parietal gyri. IC10 
had a contiguous region in either hemisphere comprising operculum, primary sensory and motor cortices, 
mid-frontal gyrus, and anterior insula, which may represent synthesis of internal states to give rise to 
emotional processing and interpretation. IC11 was a motor execution network comprised almost 
exclusively of pre-central gyrus activity, thalamus, and both anterior and posterior medial cerebellum. 
IC12 was a sensorimotor network that almost exclusively included pre- and post-central gyri. IC13 was a 
right executive function network comprised of inferior and parietal gyri. IC14 was a fronto-cingular 
network composed of all segments of cingulate gyrus except for the rostrum, as well as medial frontal 
gyrus. IC15 was a cerebellar network that exclusively encompassed cerebellum. IC16 was comprised of 
dorsolateral prefrontal and anterior cingulate cortices, suggesting that this may be a frontopolar network 
involving in top-down control of cognitive and/or affect processes. IC17 comprised activation exclusively 
in superior temporal sulcus, suggesting a network revolving around Wernicke’s area and therefore 
comprehension and production of coherent speech. IC18 touched on basal ganglia, motor, and pre-motor 
regions, suggesting a motor coordination loop. IC19 had activation almost exclusively in primary visual 
cortex with no impingement on extrastriate regions, which was highly posterior compared to IC8 which 
did not have the most posterior part of occipital cortex. IC20 comprised the posterior portion of Default 
Mode Network. IC21 was a complex neural network to interpret, with activation hot-spots predominantly 
in bilateral inferior frontal gyrus, as well as left superior mediofrontal and orbitofrontal gyri, precuneus, 
and left medial temporal cortex. This network may involve top-down cognitive processing of object 
stimuli in the ‘what’ pathway.
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CHAPTER 4. GENERAL CONCLUSION 
 Cognitive dysfunction accompanies older adults with AD. Overall, it seems that some 
genotypes are at higher risk for AD, which is further exacerbated by diet and lifestyle. 
Potentially detrimental TOMM40 '650 genotypes may reflect issues with mitochondrial function, 
glucose regulation, and other issues that are similarly dysregulated by less healthy or poor 
dietary choices. Thorough examination of neural networks with genetic variation could uncover 
the mechanism behind dysregulated neural processing, and by extension establish or validate 
factors that influence cognition.   
 First, Study 1 indicated that daily cheese intake was related to increased FI at baseline 
regardless of APOE4 carriage status. Though daily cheese intake was related to increased FI for 
adults without family history, but this association was not observed in adults with family history.  
Additionally, weekly cheese intake had a positive association with FI over time for APOE4+ 
only. Since whole-foods may be related to FI cross-sectionally and over time, dietary 
interventions should be implemented with AD risk factors in consideration.  
 Second, Study 2 suggested that APOE haplotype was related with functional 
connectivity. Specifically, ε4 in contrast with ε3, was related to reduced functional connectivity 
in several resting neural networks such as memory consolidation, posterior default mode network 
and top-down cognitive processing. On the other hand, TOMM40 ‘650 G allele was associated 
with increased functional connectivity in men. Functional connectivity appears to be a useful 
biomarker to discern impact of genetic risk factors.  
 
 
